David D. O'Toole, Chief Financial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 432 shares at $30.60 ($13K) on 2022-01-10, disclosed to the SEC on 2022-01-12.
Open-market sale of $13k OPNT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RCEL | BUY | 2026-03-11 | $9K | — | Filing → |
| RCEL | BUY | 2026-02-23 | $12K | — | Filing → |
| RCEL | BUY | 2025-08-26 | $9K | — | Filing → |